The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol. 2022

C Austin Zamarripa, and Matthew D Novak, and Elise M Weerts, and Ryan Vandrey, and Tory R Spindle
Behavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

The legalization of cannabis for medicinal and non-medicinal purposes, and the corresponding increase in diversity of cannabis products, has resulted an urgent need for cannabis regulatory science. Among the most pressing needs is research related to impairment due to cannabis exposure, especially on driving performance. The present project was designed to evaluate the impact of oral and vaporized cannabis, when administered alone or in combination with alcohol, on simulated driving performance (STISIM driving simulator), cognitive/psychomotor ability, and field sobriety performance. Healthy adults will complete two, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory studies, one with oral cannabis (16 men/16 women) and the second with vaporized cannabis (16 men/16 women). In each study, participants will complete seven experimental sessions during which acute doses of placebo or high Δ9-THC cannabis containing 0, 10, or 25 mg Δ9-THC will be administered both alone and in combination with placebo or alcohol-containing beverages (target breath alcohol concentrations, BAC, of 0.0% or 0.05%). A positive control session (i.e., alcohol at target BAC of 0.08% with placebo cannabis) will also be completed. Simulated driving performance tests (available for download; see Methods), field sobriety assessments, subjective drug effect questionnaires, a mobile device impairment test (DRUID app), and collection of whole blood specimens will be completed repeatedly during each session. Linear mixed models will be used to test for differences across experimental conditions and a priori planned comparisons will be used to determine differences between conditions of interest (e.g., cannabis alone vs cannabis with alcohol). This research is designed to extend prior studies of cannabis and alcohol on driving performance by using oral and vaporized routes of cannabis administration. By increasing understanding of impairment associated with co-use of alcohol and these novel forms of cannabis, this research could inform impairment detection standards for cannabis and alcohol and have important implications for law enforcement, public policy decisions regarding accessibility of these substances, and education of the general population who may use cannabis and/or alcohol. Lastly, this manuscript provides interested researchers with access to the simulated driving scenarios and data extraction tools developed for this study as a means of facilitating future cross-study comparisons, which is important given the heterogeneity in methods used across laboratories in prior research.

UI MeSH Term Description Entries

Related Publications

C Austin Zamarripa, and Matthew D Novak, and Elise M Weerts, and Ryan Vandrey, and Tory R Spindle
October 2018, Fundamental & clinical pharmacology,
C Austin Zamarripa, and Matthew D Novak, and Elise M Weerts, and Ryan Vandrey, and Tory R Spindle
February 2020, Translational psychiatry,
C Austin Zamarripa, and Matthew D Novak, and Elise M Weerts, and Ryan Vandrey, and Tory R Spindle
March 2014, Sleep,
C Austin Zamarripa, and Matthew D Novak, and Elise M Weerts, and Ryan Vandrey, and Tory R Spindle
March 2000, Annals of internal medicine,
C Austin Zamarripa, and Matthew D Novak, and Elise M Weerts, and Ryan Vandrey, and Tory R Spindle
April 2012, Journal of psychiatric research,
C Austin Zamarripa, and Matthew D Novak, and Elise M Weerts, and Ryan Vandrey, and Tory R Spindle
December 2022, Psychopharmacology,
C Austin Zamarripa, and Matthew D Novak, and Elise M Weerts, and Ryan Vandrey, and Tory R Spindle
September 2020, Human psychopharmacology,
C Austin Zamarripa, and Matthew D Novak, and Elise M Weerts, and Ryan Vandrey, and Tory R Spindle
August 2014, Drug and alcohol dependence,
C Austin Zamarripa, and Matthew D Novak, and Elise M Weerts, and Ryan Vandrey, and Tory R Spindle
July 2011, The Clinical neuropsychologist,
C Austin Zamarripa, and Matthew D Novak, and Elise M Weerts, and Ryan Vandrey, and Tory R Spindle
September 2021, Diabetes, obesity & metabolism,
Copied contents to your clipboard!